Genomic profiling for metastatic breast cancer in Spain
Part of Cancer, Skin clinical trials.
This study looks at how genetic testing of your tumor might affect the treatment plan for your metastatic breast cancer. It aims to help doctors choose the best therapy based on your tumor's profile.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman or man living in Spain.
- You are 18 years old or older.
- You are able to take care of yourself (up and about more than 50% of the time).
- You have metastatic breast cancer that either came back while you were on hormone-blocking therapy (ER+/HER2-) and you haven't started treatment yet, or your metastatic cancer has gotten worse after at least one previous treatment.
- You have not had more than 3 rounds of chemo or antibody-drug conjugates for your metastatic cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized treatment approach for people with metastatic (advanced spread) breast cancer using tumor testing. It may help guide doctors toward better-matched therapies based on genomic (DNA) information from your tumor.
This study looks at using a simple blood test (liquid biopsy) to read tumor DNA and understand how it could affect treatment decisions. It is for adults with metastatic prostate cancer who are about to start, are receiving, or recently finished treatment.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This study looks at the genetic makeup of metastatic prostate cancer in a Brazilian patient group. It aims to find markers that might help guide future treatment decisions.
This study helps doctors use more individualized (precision) treatment choices for people with certain advanced cancers. You may be offered study care based on your cancer details, aiming to improve treatment decisions.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.